SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000950162-09-000088
Filing Date
2009-02-20
Accepted
2009-02-20 14:08:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 DOR BIOPHARMA/SIGMA TAU INTERNATIONAL SCHEDULE 13D - 02/11/09 sigmatauinter13d_021109.htm SC 13D 236536
  Complete submission text file 0000950162-09-000088.txt   238639
Mailing Address 850 BEAR TAVERN ROAD SUITE 201 EWING NJ 08628
Business Address 850 BEAR TAVERN ROAD SUITE 201 EWING NJ 08628 609-538-8200
DOR BIOPHARMA INC (Subject) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-39976 | Film No.: 09624543
SIC: 2834 Pharmaceutical Preparations

Mailing Address 18 AVENUE DE LA PORTE NEUVE LUXEMBOURG N4 L-2227
Business Address 18 AVENUE DE LA PORTE NEUVE LUXEMBOURG N4 L-2227
SIGMA TAU INTERNATIONAL SA (Filed by) CIK: 0001170881 (see all company filings)

IRS No.: 000000000
Type: SC 13D